Welfarma
Agreement for management companies, trade unions redundancies pharmaceutical companies and unions 'allies' to facilitate retraining and redeployment of surplus staff in the pharmaceutical sector. Sector that has 5 thousand 'cuts' of staff from 2007 to present, for most graduates, whose number is expected to grow in coming years. With these objectives, Farmindustria Filcem-CGIL, CISL and Femca-Uilcem-Uil signed yesterday an agreement for that purpose. "This is an act of social responsibility, strongly backed by unions and businesses, and a concrete example of bilateral management for the protection of employees through guided tours in the labor market," they said. The 'Welfarma' is the name of the new welfare model - refer Farmindustria and trade unions - is a voluntary instrument of extraordinary innovation that sits alongside the existing contractual provisions and the law, without extra cost to the company . It does not require new resources, but uses what is already available as a shock social skills training and contributions all'autoimprenditorialità. Enable companies involved to address the redundant staff to related areas, sectors or other businesses of their own. The innovation of Welfarma is to make available to companies and workers a network that is based on collaboration between the private employment agencies and the Ministry of Welfare in Italy will request the activation of Labor. The re-targeted to the characteristics of the person and the market potential, training and support in the design and initiation of future work are the strengths of Welfarma. The project is part of a new social model that will involved government, regions and local authorities, consistent with the industrial relations of the chemical and pharmaceutical industry that provide 'a robust welfare negotiation'. It 's a flexible response - still continuing - the downsizing of employment in pharmaceutical companies due to a profound transformation of the sector nationally and internationally. A transformation dictated by the increasingly high costs of R & D, the competitive pressure, the specialization in organizational models and patent dates. Just to find solutions to the challenges of the industry - remember - was established in the Ministry of Economic Development Table for the pharmaceutical, home that has recognized the value industrial and scientific enterprises of the country of the drug. The agreement and the table - end - are two important steps since the industry exceeds this sensitive stage and raise and nurture their investments in Italy.
0 comments:
Post a Comment